158 related articles for article (PubMed ID: 24679064)
1. Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
Francer J; Izquierdo JZ; Music T; Narsai K; Nikidis C; Simmonds H; Woods P
Philos Ethics Humanit Med; 2014 Mar; 9():7. PubMed ID: 24679064
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
Vilhelmsson A; Davis C; Mulinari S
PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
[TBL] [Abstract][Full Text] [Related]
3. Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.
Zetterqvist AV; Merlo J; Mulinari S
PLoS Med; 2015 Feb; 12(2):e1001785. PubMed ID: 25689460
[TBL] [Abstract][Full Text] [Related]
4. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
Leonardo Alves T; Lexchin J; Mintzes B
Sci Eng Ethics; 2019 Aug; 25(4):1167-1192. PubMed ID: 29721844
[TBL] [Abstract][Full Text] [Related]
5. A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation.
Li S; Gibbs I
J Pharm Pharm Sci; 2021; 24():381-389. PubMed ID: 34314671
[TBL] [Abstract][Full Text] [Related]
6. Drug Promotions Between Ethics, Regulations, and Financial Interests.
Astărăstoae V; Rogozea LM; Leaşu FG; Roşca S
Am J Ther; 2024 May-Jun 01; 31(3):e268-e279. PubMed ID: 38691666
[TBL] [Abstract][Full Text] [Related]
7. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
[TBL] [Abstract][Full Text] [Related]
8. [Case: bioethical disputes of the donations of the pharmaceutical companies to the health centers].
González-González A
Cuad Bioet; 2020; 31(103):423-427. PubMed ID: 33375807
[TBL] [Abstract][Full Text] [Related]
9. Spin your science into gold: direct to consumer marketing within social media platforms.
Egilman D; Druar NM
Work; 2012; 41 Suppl 1():4494-502. PubMed ID: 22317414
[TBL] [Abstract][Full Text] [Related]
10. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
[TBL] [Abstract][Full Text] [Related]
11. Scientific misconduct, the pharmaceutical industry, and the tragedy of institutions.
Cohen-Kohler JC; Esmail LC
Med Law; 2007 Sep; 26(3):431-46. PubMed ID: 17970244
[TBL] [Abstract][Full Text] [Related]
12. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
Lexchin J
CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
[TBL] [Abstract][Full Text] [Related]
13. Medical Marketing in the United States, 1997-2016.
Schwartz LM; Woloshin S
JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
[TBL] [Abstract][Full Text] [Related]
14. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
D'Hooghe T
Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
[TBL] [Abstract][Full Text] [Related]
15. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.
Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P
PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484
[TBL] [Abstract][Full Text] [Related]
16. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
Civaner M
Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
[TBL] [Abstract][Full Text] [Related]
17. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis.
Czerw A; Religioni U
Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622
[TBL] [Abstract][Full Text] [Related]
18. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
Arnold DG; Oakley JL
J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
[TBL] [Abstract][Full Text] [Related]
19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
20. [Charter of medicines promotion and rational use by physicians].
Baumevieille M; Bégaud B; Maurain C
Therapie; 2007; 62(1):39-44. PubMed ID: 17374346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
